CXCL2 and Autoimmunity: Reducing ALKBH5 resulted in heightened m6A modification on IFNG and recombinant human C-X-C motif chemokine 2 (CXCL2) mRNA, impairing CD4+ T cell responses and contributing to the suppression of autoimmunity (131).